Aims: To explore the factors that position nurse practitioners (NPs) to lead the implementation of HIV pre-exposure prophylaxis.
| AIMS
Public health approaches for the prevention of HIV infection have expanded in recent years to include oral antiretroviral therapy as preexposure prophylaxis (PrEP). Currently, the only form of PrEP approved for prevention indication consists of a daily oral medication containing co-formulated emtricitabine and tenofovir disoproxil fumarate (FTC/TDF, brand name Truvada; Gilead Sciences). When taken as directed, the use of Truvada for PrEP has demonstrated over 95% efficacy in preventing HIV transmission in several clinical trials (Grant et al., 2010; Hosek et al., 2017; Liu et al., 2016) . However, despite the overwhelming evidence of its prevention efficacy, uptake and implementation of PrEP remain suboptimal. A major anticipated benefit of PrEP is the promise it holds for reducing racial/ethnic disparities in HIV infection; however, to date, this potential benefit has not been realised. One important consideration of PrEP implementation is the way that healthcare professionals can be organised to optimise its delivery and management. Several factors combine to place nurse practitioners in an ideal position to lead PrEP care delivery.
The aim of this article was to explore the factors that position nurse practitioners (NPs) to lead the delivery of HIV PrEP and thereby advancing global efforts to end the epidemic by reducing new HIV infections. Advanced practice nursing frameworks provide details of strategies for applying advanced practice nursing competencies to the implementation of new evidence to address health problems, such as PrEP for HIV prevention (Brown, 1998; Bryant-Lukosius & Dicenso, 2004; Bryant-Lukosius et al., 2016) . While this article focuses on domestic US scale-up, the potential also exists for NPs to accelerate (Hess, Hu, Lansky, Mermin, & Hall, 2017) . This group is the highest priority population for PrEP; however, they represent only 10% of PrEP users (Bush et al., 2016) . Finally, there are also disparities in HIV infection by geographic region; in 2015, rates of new HIV infections in the south were 16.8 per 100,000 compared with 11.6 in the north-east, 9.8 in the west and 7.6 in the Midwest (CDC, 2016; Hess et al., 2017) .
| HIV PrEP care continuum
In 2017, researchers developed the schema for a PrEP Care Continuum (Nunn et al., 2017) . This model posits that clinical engagement regarding PrEP begins with raising awareness via health education and outreach activities. This is followed by facilitating PrEP access, linking to PrEP care and prescribing PrEP. Regarding PrEP provision, the provider and patient must first agree that, based on the patient's HIV risk behaviours, the patient is a good candidate for PrEP. Once this has been determined, but before PrEP is prescribed, it is necessary to evaluate the patient for sexually transmitted infections (STIs) and acute HIV infection; the latter is crucial, given that PrEP use may lead to antiretroviral resistance among those who already have an HIV infection. Providers must also assess the patient's renal function and test for infection with hepatitis B virus to ensure that PrEP is safe for the patient to use. In the HIV PrEP care continuum, clinical engagement culminates with adherence to the treatment plan and programme retention (Nunn et al., 2017) . Quarterly health assessments are required to assess side effects, provide adherence and sexual risk reduction counselling, perform regular monitoring for HIV and renal function and prescribe the next 90-day supply of medication (CDC, 2014) .
| METHODS
The arguments in this paper are grounded in the current literature on HIV PrEP implementation and evidence of the added value of nurse-based models in promoting health outcomes. This includes research and policy literature on advanced practice nursing frameworks and nurse-led care coordination. The American Association of Colleges of Nursing's advanced nursing practice competencies (American Association of Colleges of Nursing, 2006) were also included for identifying and cross-referencing nurse practitioner assets that align with PrEP care continuum outcomes (see Table 1 ).
What does this paper contribute to the wider global clinical community?
• HIV pre-exposure prophylaxis has potential to curb the HIV pandemic. Advanced practice nursing frameworks can help accelerate global implementation of HIV preexposure prophylaxis in countries where the nurse practitioner role exists.
• Nurse practitioner education programmes can explore ways to integrate the clinical management of HIV preexposure prophylaxis into their primary healthcare curriculum.
• Nurses prepared with professional clinical doctorates can take the lead in designing and implementing HIV preexposure prophylaxis programmes based on advanced practice frameworks.
| DISCUSSION
The CDC estimates that over 1.2 million people in the United States would benefit from taking PrEP; most of whom are from marginalised or vulnerable population groups (e.g., sexual and racial minority groups such as Black MSM, residents of low-socioeconomic communities). However, uptake of PrEP among these groups remains at a critical low. For example, two recent studies of diverse samples of MSM found that despite high levels of interest in PrEP, only about 4% used PrEP as a prevention strategy (Hoots et al., 2016; Rolle et al., 2017) . The most recent data from the CDC indicated that Blacks represent the highest numbers of people who would benefit from PrEP (44%), yet only account 1% of individuals receiving prescriptions for PrEP (Smith, Van Handel & Grey, 2018) . This can be partly explained by the lack of awareness of PrEP among high-risk groups (Eaton et al., 2015) , but other barriers to PrEP use have also emerged in the literature (Elopre et al., 2017; Lancki et al., 2018 
Retention in PrEP care
Essential VIII. Advanced nursing practice competencies Conduct a comprehensive and systematic assessment of health and illness parameters in complex situations, incorporating diverse and culturally sensitive approaches.
Design, implement and evaluate therapeutic interventions based on nursing science and other sciences.
Develop and sustain therapeutic relationships with patients and other professionals to facilitate optimal care and patient outcomes.
Demonstrate advanced levels of clinical judgement, systems thinking and accountability in designing, delivering and evaluating evidence-based care to improve patient outcomes.
Guide, mentor and support other nurses to achieve excellence in nursing practice.
Educate and guide individuals and groups through complex health and situational transitions.
Use conceptual and analytic skills in evaluating the links among practice, organisational, population, fiscal and policy issues. inequalities that can complicate health promotion and disease prevention efforts, such as engagement in PrEP clinical services (Brewer et al., 2014a,b; Cohen et al., 2007; Dray-Spira et al., 2005; Ickovics et al., 2002; Marshall, Shannon, Kerr, Zhang, & Wood, 2010; Quinn, Kaufman, Siddiqi, & Yeatts, 2010; VanDevanter et al., 2011) . In a study comparing 40 US counties with the highest and lowest increases in AIDS cases, researchers found that the counties with highest proportional increases in AIDS also had the lowest literacy, educational level and annual earnings (Peterman, Lindsey, & Selik, 2005) . In a six-city US study of HIV risks among Black MSM, social, economic and legal hardships were associated with increased odds of the presence of behaviours or clinical factors for which PrEP is indicated . For example, recent job loss was associated with increased odds of condomless anal intercourse in the past 6 months, recent conviction and unstable housing were both associated with increased odds of recent history of STI, and recent financial crisis was associated with two or more sexual partners in the past six months. In sum, those who are at greatest risk for HIV, and therefore, the highest priority for
PrEP have circumstances that present serious challenges to PrEP uptake.
Barriers to PrEP use also include complex psychosocial circumstances, such as active substance use and concerns about shortand long-term side effects of antiretroviral medication. Mistrust of medical establishments and the anticipation of being stigmatised during medical visits also emerged as factors that undermine healthcare seeking behaviours (such as HIV testing), which consequently limit opportunities for patients to access PrEP clinical care (Cahill et al., 2017; Eaton et al., 2014) . Patients' race is also a factor associated with decreased PrEP use (Adams & Balderson, 2016; Calabrese, Earnshaw, Underhill, Hansen, & Dovidio, 2014; Kuhns, Hotton, Schneider, Garofalo, & Fujimoto, 2017) . A recent large-scale analysis of 45,000 prescriptions filled between 2011-2014 found that Black women were more than four times less likely than White women to be prescribed PrEP, even though they comprise 62% of new HIV infections (Bush et al., 2016) . This is consistent with data from the same study which indicated that Blacks were given 10%
of PrEP prescriptions compared with 74% of prescriptions that were given to Whites (Bush et al., 2016) . These race-based gaps between patient's affirmative interest in PrEP and the prescribing patterns of providers may reflect structural inequities (e.g., low insurance coverage among Blacks, implicit racial bias among healthcare providers) that limit access to PrEP (Calabrese et al., 2014) . Other social predictors of PrEP use include having health insurance coverage, stable housing and access to ancillary supportive health services . Patients that do have access to these types of resources experience difficulties in prioritising PrEP among their other competing life demands (Logan, Cole & Leukefeld, 2002) . These individual-level circumstances and system-level challenges converge and can form an interlocked multi-level barrier for patients who would benefit from PrEP; thus, both levels must be targeted to facilitate PrEP implementation.
| Barrier 2: Perceived clinical complexity of antiretroviral medication use in HIV non-infected individuals
Awareness of PrEP among non-HIV clinical providers has been low, and prescription rates among all providers are also low, although increasing over the past few years. For example, recent surveys of HIV care providers found that only 26%-64% had prescribed PrEP, and only 16% of primary care providers had prescribed PrEP Weiser, et al. 2017) . A number of factors likely contribute to low rates of prescribing. These include a mix of skills among providers that are not equitable across clinical practice settings. STI clinics are set-up for urgent care and are not designed for longitudinal follow-up of patients seeking sexual health services.
Therefore, an STI clinic provider may be reluctant to prescribe PrEP In addition, numerous studies have reported higher satisfaction among patients seen by NPs, which is a strong predictor of retention in care and adherence to treatment/prevention care plans (Jennings, Clifford, Fox, Oconnell, & Gardner, 2015) . In addition to the NP advantage in the health education domain, NPs are more likely than physicians to provide care to patients whose intersecting psychosocial complexities of life complicate efforts to achieve and maintain prevention goals (Dahrouge et al., 2014) . The NP is well-prepared for these scenarios through their training on assessing the patient's health situa- intervention, there is a well-established history of using APN frameworks to systematically accelerate the implementation of new evidence to improve patient outcomes (Brown, 1998; Bryant-Lukosius & Dicenso, 2004; O'Connell, Gardner, & Coyer, 2014) . Figure 1 presents an example of applying the PEPPA framework for HIV PrEP.
Another important tool that NPs can use to facilitate PrEP scaleup is through their ability to lead care coordination of patients with complex health profiles (American Academy of Ambulatory Care
Nursing, 2015). Care coordination models are designed to be responsive to the realities of life that can undermine patients' abilities to achieve their health goals by facilitating connections across the various domains that are complicating the patients' health care. For many Black MSM-the highest priority population for domestic HIV PrEP uptake-these complicating realities include high rates of unemployment, housing instability, incarceration and substance abuse, structural racism and homophobia (Nelson, Walker, DuBois, & Giwa, 2014; Nelson et al., 2016 Nelson et al., , 2017 . Raleigh/Durham). In HPTN 073, participants were followed for 12 months but were not obligated to take PrEP at any time during the study. Nonetheless, PrEP uptake was high at 79%, with 68% of those who started PrEP continuing to use it at 6 month post-F I G U R E 1 Sample application of PEPPA advanced practice nursing framework to pre-exposure prophylaxis (PrEP) implementation [Colour figure can be viewed at wileyonlinelibrary.com] enrolment (Wheeler et al., 2016) . Nursing as a profession and NPs as a specific APN role already have a head start for acting on the HPTN 073 study results because a solid nursing evidence-base exists for the effectiveness of care coordination in significantly improving patient outcomes in areas of health where there are persistent racial/ethnic health disparities (Haas & Swan, 2014; Mason et al., 2013; Tringali, Murphy, & Osevala, 2008; Wong et al., 2016; Young et al., 2013) . (Everett, Schumacher, Wright, & Smith, 2009; Grumbach, Hart, Mertz, Coffman, & Palazzo, 2003) . In addition, NPs are more likely to function as a usual source of care in rural areas than in urban areas, which signifies the essential role of NPs in expanding care provision for rural populations, such as regions of the global south which are high priority geographic areas for PrEP care (Davis, Guo, Titler, & Friese, 2017) . Furthermore, as NP residencies proliferate, there is an opportunity to mentor new NPs to become PrEP champions as they move into their post-residency careers in a wide range of clinical practice settings.
|

| Illustrative clinical case example
A 20-year-old male patient from a small-scale urban centre presented Nonetheless, the use of APN frameworks for developing PrEP implementation strategies internationally can be tailored so that they are aligned with the local practice standards and contribute to HIV PrEP scale-up in those contexts.
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